Loading…
Loading…
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
Anthropic is heading toward a potential blockbuster IPO, fueled by rapid revenue growth, major AI deals and ambitious valuation targets.
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 De
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
The 2026 IPO window blew open this summer. SpaceX's June listing pulled in a reported $86 billion according to Benzinga and other outlets, and Anthropic is now being floated as the next challenger to that record, with OpenAI chatter never far behind.
IP Group PLC (LSE:IPO) has seen a bullish write-up from European investment bank Berenberg, which pitches a 'Buy' rating and a 119p price target that implies around 70% upside to its current price. Berenberg describes IP Group, the investor in early-stage companies, as an “underappreciated asset” whilst noting the current 40% discount to NAV despite improving portfolio valuations and a strong liquidity position.
Black Rock Coffee Bar, Inc. Notice of August 17, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sob
[url="]Seaport Therapeutics, Inc.[/url], (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company that is inventing and develo